Aberrant expression of SMARCB1 has been found in a variety of tumors, such as pancreatic rhabdoid carcinoma (7), yolk sac tumors (8) thoracic neoplasms (9), soft-tissue neoplasms (10) and renal cancer (11). This evidence concerns the gene SMARCB1 and soft tissue neoplasm.